Clinical Trial Update: Low-dose Gonal-f® in Ovulation Induction [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating low-dose Gonal-f (follitropin alfa) for ovulation induction in infertility was terminated, with results posted in August 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility
• Monofollicular Development

Drugs mentioned

• Gonal-F (follitropin alfa)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Infertility, Monofollicular Development | Phase 4 | Status: TERMINATED | Results posted: 2016-08-11